ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

ONVO Organovo Holdings Inc

0,96
-0,11 (-10,28%)
02 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Organovo Holdings Inc ONVO NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,11 -10,28% 0,96 01:50:21
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,98 0,9305 1,02 0,9311 1,07
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
15.4.202414:05GLOBEOrganovo Announces Positive Phase 2 Results for FXR314 in..
09.2.202406:15EDGAR2Form EFFECT - Notice of Effectiveness
08.2.202422:56EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08.2.202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.2.202414:05EDGAR2Form 8-K - Current report
26.1.202423:09EDGAR2Form S-3 - Registration statement under Securities Act of..
25.1.202414:05GLOBEOrganovo Presents FXR314 3D Human Tissue Model Findings That..
09.1.202414:05GLOBEOrganovo To Present FXR314 IBD 3D Model Findings at Upcoming..
28.12.202322:05EDGAR2Form 8-K - Current report
22.12.202312:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06.12.202314:05GLOBEOrganovo Provides Timing for Release of FXR314 Phase 2 NASH..
01.12.202322:07EDGAR2Form S-8 - Securities to be offered to employees in employee..
18.11.202300:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.11.202300:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.11.202300:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.11.202300:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.11.202300:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.11.202322:41EDGAR2Form 144 - Report of proposed sale of securities
13.11.202314:05GLOBECORRECTION – Organovo Highlights FXR314 Combination Therapy..
09.11.202323:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.11.202314:05GLOBEOrganovo Highlights FXR314 Combination Therapy Potential and..
03.11.202313:05EDGAR2Form 8-K - Current report
22.9.202322:05EDGAR2Form 8-K/A - Current report: [Amend]
13.9.202323:06EDGAR2Form DEF 14A - Other definitive proxy statements
13.9.202323:06EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12.9.202322:11EDGAR2Form 8-K - Current report
08.9.202318:46GLOBEOrganovo to Participate in the H.C. Wainwright Global..
05.9.202312:04EDGAR2Form 8-K - Current report
23.8.202314:05GLOBEOrganovo Advances Clinical Timelines for FXR314 and Provides..
22.8.202322:45EDGAR2Form 8-K - Current report
10.8.202322:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31.7.202322:05EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
24.7.202322:27EDGAR2Form 8-K - Current report
14.7.202323:05EDGAR2Form PRE 14A - Other preliminary proxy statements
29.6.202322:06EDGAR2Form NT 10-K - Notification of inability to timely file Form..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock